Abstract:Background: Radioresistance is the leading cause of treatment failure for nasopharyngeal carcinoma (NPC). Therefore, screening the critical regulators in radioresistance and revealing the underlying mechanisms is imperative for improvement of therapeutical efficacy in NPC. Materials and methods: Our previous study has proved that miR-181a may serve as a pro-radioresistant miRNA. In this study, we explored the expression of miR-181a in NPC, especially in radioresistant NPC samples, by qPCR. Moreover, the clinical significance of miR-181a level was also analyzed. Furthermore, the functions of miR-181a, both in vitro and in vivo, were detected via a serial of assays such as CCK-8, plate clone survival, apoptosis, and xenograft tumor model. The downstream target of miR-181a was also validated by dual luciferase reporter assay and the roles of miR-181a's target in the regulation of NPC radioresistance were investigated. Results: The results revealed that miR-181a was significantly upregulated in NPC, especially in radioresistant NPC. MiR-181a level is positively correlated to lymph node metastasis and advanced TNM stages and negatively associated with overall survival rate in NPC. Ectopic expression of miR-181a in radiosensitive NPC cells, or overexpression of miR-181a inhibitor in radioresistant NPC cells, could enhance or impair the radioresistance of NPC cells supported by the results from both in vitro and in vivo, respectively. Mechanistically, dual luciferase report assay indicated that miR-181a could directly target RKIP. Moreover, both in vitro and in vivo experimental outcomes indicated that RKIP restoration and knockdown could antagonize the effects of miR-181a and miR-181a inhibitor in the regulation of NPC radioresistance. Conclusion: Collectively, the findings of this study proved that miR-181a is upregulated and promotes radioresistance by targeting RKIP in NPC. Targeting miR-181a/RKIP axis may be a valid path for reinforcing radiosensitivity and eventually improving the outcomes of clinical treatment in NPC.

PRKCI Mediates Radiosensitivity <i>via</i> the Hedgehog/GLI1 Pathway in Cervical Cancer

PRKCI Mediates Radiosensitivity via the Hedgehog/GLI1 Pathway in Cervical Cancer

Icotinib Hydrochloride Enhances Chemo- And Radiosensitivity By Inhibiting Egfr Signaling And Attenuating Rad51 Expression And Function In Hela S3 Cells

Data from Integrative Analysis Identifies a Novel AXL–PI3 Kinase–PD-L1 Signaling Axis Associated with Radiation Resistance in Head and Neck Cancer

The PIK3CA-E545K-SIRT4 Signaling Axis Reduces Radiosensitivity by Promoting Glutamine Metabolism in Cervical Cancer

Targeting of -Catenin Reverses Radioresistance of Cervical Cancer with the <i>PIK3CA</i>-E545K Mutation

Knockdown of PKM2 enhances radiosensitivity of cervical cancer cells

Data from Targeting of β-Catenin Reverses Radioresistance of Cervical Cancer with the <i>PIK3CA</i>-E545K Mutation

CPT1A Mediates Radiation Sensitivity in Colorectal Cancer

Phosphoinositide-3-kinase Inhibition Enhances Radiosensitization of Cervical Cancer in Vivo.

Inhibition of EGFR Nuclear Translocation Attenuate Radioresistance Through Decreased P-Dna-pk Expression in Cervical Cancer Cells.

PI3Kα Inhibitors Sensitize Esophageal Squamous Cell Carcinoma to Radiation by Abrogating Survival Signals in Tumor Cells and Tumor Microenvironment.

The Inhibition Of Egfr Nuclear Translocation Attenuates Radioresistance Through Decreasing The Expression Of P-Dna-Pk In Cervical Cancer Cells

Association of Protein Kinase CK2 Inhibition with Cellular Radiosensitivity of Non-Small Cell Lung Cancer

PKI-587 enhances radiosensitization of hepatocellular carcinoma by inhibiting the PI3K/AKT/mTOR pathways and DNA damage repair

PKCα is a Potentially Useful Marker for Planning Individualized Radiotherapy for Nasopharyngeal Carcinoma

Mir-181A Upregulation Promotes Radioresistance of Nasopharyngeal Carcinoma by Targeting RKIP

KCNQ1 opposite strand/antisense transcript 1 promotes aggressive biological behaviors of cervical cancer cells via regulating microRNA-491-5p and pyruvate kinase M1/2

Reduced RKIP Enhances Nasopharyngeal Carcinoma Radioresistance by Increasing ERK and AKT Activity.

Inhibition of PI3K/AKT pathway enhances radiosensitization of cervical cancer in vivo

Inhibition of Both EGFR and IGF1R Sensitized Prostate Cancer Cells to Radiation by Synergistic Suppression of DNA Homologous Recombination Repair